Drug Profile
Influenza vaccine - Beijing Minhai Biotechnology
Alternative Names: Inactivated Influenza vaccine - Beijing Minhai BiotechnologyLatest Information Update: 30 Dec 2021
Price :
$50
*
At a glance
- Originator Beijing Minhai Biotechnology
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 28 Jan 2018 No recent reports of development identified for phase-I development in Influenza-virus-infections(Prevention) in China (Parenteral, Injection)